Physics and Clinical Aspects of Brachytherapy

Brachytherapy was the original intensity‐modulated radiotherapy, providing the ability to deliver high doses to custom‐shaped targets while preserving normal, neighboring structures. Brachytherapy has many manifestations, for example permanent implants and treatments using high‐dose rate and remote afterloaders. The treatments may be executed by placement of needles or catheters into a tumor or placement of the sources in body cavities near the tumor. The choice of sources, approaches and techniques should be dictated by the patient’s presentation. The rate of treatment delivery affects both the biological results of the radiation and the physical facets of therapy. Biologically, low‐dose rate treatments tend to be relatively gentler to normal tissues but high‐dose rate approaches provide more stable and precise dose distributions. Most commonly, dose distribution calculations follow the protocol of Task Group 43 of the American Association of Physicists in Medicine, computing the doses or dose rates in space from each source separately and adding them together to obtain the composite. At the time of writing, commercial treatment planning systems have just begun to incorporate computational algorithms that can include the effects of tissue composition and density. Brachytherapy has moved from simple localization using planar images from radiographs that identify source positions and skeletal anatomy to volume imaging that also shows soft tissues and allows identification of target and normal tissue structures. Physiological and molecular imaging can further enhance the ability to shape target volumes, just as with external‐beam treatments. Treatment planning entails decisions on the approach to the brachytherapy. The classical systems, such as the Paris or Manchester systems, provide guidance for source or needle distributions that results in more controlled dose distributions from the modern optimization routines. These systems, along with other measures of implant quality, also serve as benchmarks for quality‐assurance evaluations of an application.

[1]  L E Reinstein,et al.  A new genetic algorithm technique in optimization of permanent 125I prostate implants. , 1998, Medical physics.

[2]  J F Williamson,et al.  On the validity of the superposition principle in dose calculations for intracavitary implants with shielded vaginal colpostats. , 2001, Medical physics.

[3]  Y Yu,et al.  A genetic algorithm for the optimization of prostate implants. , 1996, Medical physics.

[4]  D. Brenner,et al.  Fractionated high dose rate versus low dose rate regimens for intracavitary brachytherapy of the cervix. I. General considerations based on radiobiology. , 1991, The British journal of radiology.

[5]  C. Perez,et al.  Principles and Practice of Radiation Oncology , 1987 .

[6]  P. Grigsby,et al.  Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix. , 2005, International journal of radiation oncology, biology, physics.

[7]  M. Ferris,et al.  An iterative sequential mixed-integer approach to automated prostate brachytherapy treatment plan optimization. , 2001, Physics in medicine and biology.

[8]  R. M. Wilenzick,et al.  Brachytherapy as the sole method of breast irradiation in tis, T1, T2, No-1 breast cancer , 1994 .

[9]  C. Ling Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model. , 1992, International journal of radiation oncology, biology, physics.

[10]  D. Yan,et al.  Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy. , 1995, International journal of radiation oncology, biology, physics.

[11]  D Tubic,et al.  Automated seed detection and three-dimensional reconstruction. I. Seed localization from fluoroscopic images or radiographs. , 2001, Medical physics.

[12]  M Saiful Huq,et al.  Third-party brachytherapy source calibrations and physicist responsibilities: report of the AAPM Low Energy Brachytherapy Source Calibration Working Group. , 2008, Medical physics.

[13]  P. Levendag,et al.  Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments. , 1996, International journal of radiation oncology, biology, physics.

[14]  Dattatreyudu Nori,et al.  An atlas of brachytherapy , 1988 .

[15]  Icru Prescribing, recording, and reporting photon beam therapy , 1993 .

[16]  J. Williamson,et al.  Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. , 2004 .

[17]  E. Quimby Dosage Table for Linear Radium Sources , 1944 .

[18]  P. Grimm,et al.  American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[19]  D. Baltas,et al.  A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[20]  W. Butler,et al.  Supplement to the 2004 update of the AAPM Task Group No. 43 Report. , 2007, Medical physics.

[21]  Hualin Zhang,et al.  Dose verification with Monte Carlo technique for prostate brachytherapy implants with (125)I sources. , 2005, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[22]  M Zaider,et al.  Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sources. , 1996, International journal of radiation oncology, biology, physics.

[23]  Zhe Chen,et al.  Relative Biological Effectiveness of 103Pd and 125I Photons for Continuous Low-Dose-Rate Irradiation of Chinese Hamster Cells , 2005, Radiation research.

[24]  A L Boyer,et al.  A dose-volume histogram based optimization algorithm for ultrasound guided prostate implants. , 2000, Medical physics.

[25]  P. Hoskin,et al.  Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  R. Nath,et al.  Interseed effects on dose for 125I brachytherapy implants. , 1992, Medical physics.

[27]  G. Marinello,et al.  A Practical Manual of Brachytherapy , 1997 .

[28]  Eva K. Lee,et al.  Mixed integer programming optimization models for brachytherapy treatment planning , 1997, AMIA.

[29]  S Nag,et al.  The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. , 2000, International journal of radiation oncology, biology, physics.

[30]  M. Moerland,et al.  A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. , 1997, International journal of radiation oncology, biology, physics.

[31]  L. Anderson,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .

[32]  D. Brenner,et al.  Quantitative comparisons of continuous and pulsed low dose rate regimens in a model late-effect system. , 1996, International journal of radiation oncology, biology, physics.

[33]  Frank-André Siebert,et al.  The design and testing of a solid phantom for the verification of a commercial 3D seed reconstruction algorithm. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  A Dutreix,et al.  The Paris system in interstitial radiation therapy. , 1978, Acta radiologica: oncology, radiation, physics, biology.

[35]  J. Williamson,et al.  Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source. , 1994, International Journal of Radiation Oncology, Biology, Physics.

[36]  John Strang,et al.  Automatic localization of implanted seeds from post-implant CT images. , 2003, Physics in medicine and biology.

[37]  R. Dale,et al.  A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd , 2001, Physics in medicine and biology.

[38]  M. Zaider,et al.  The Anderson nomograms for permanent interstitial prostate implants: a briefing for practitioners. , 2002, International journal of radiation oncology, biology, physics.

[39]  J. Pouliot,et al.  Optimization of permanent 125I prostate implants using fast simulated annealing. , 1996, International journal of radiation oncology, biology, physics.

[40]  S. Sim,et al.  Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose. , 2004, International journal of radiation oncology, biology, physics.

[41]  L. Sakelliou,et al.  Dose rate calculations around 192Ir brachytherapy sources using a Sievert integration model. , 2000, Physics in medicine and biology.

[42]  S. Loening,et al.  Survival of patients with localized prostate cancer treated with percutaneous transperineal placement of radioactive gold seeds: Stages A2, B, and C , 1995, The Prostate.

[43]  J. Palta,et al.  Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. , 1994, Medical physics.

[44]  Luc Beaulieu,et al.  The evolution of brachytherapy treatment planning. , 2009, Medical physics.

[45]  R Nath,et al.  Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. , 1999, Medical physics.

[46]  Richard F. Mould,et al.  Brachytherapy from radium to optimization , 1994 .

[47]  M Zaider,et al.  A calculation of the relative biological effectiveness of 125I and 103Pd brachytherapy sources using the concept of proximity function. , 1998, Medical physics.

[48]  Rakesh Patel,et al.  3D CT-based high-dose-rate breast brachytherapy implants: treatment planning and quality assurance. , 2004, International journal of radiation oncology, biology, physics.

[49]  Sasa Mutic,et al.  PET-guided three-dimensional treatment planning of intracavitary gynecologic implants. , 2002, International journal of radiation oncology, biology, physics.

[50]  R. Cormack Quality assurance issues for computed tomography-, ultrasound-, and magnetic resonance imaging-guided brachytherapy. , 2008, International journal of radiation oncology, biology, physics.

[51]  S. Loening,et al.  Percutaneous transperineal placement of gold 198 seeds for treatment of carcinoma of the prostate , 1988, The Prostate.

[52]  Bert M. Coursey,et al.  New National Air-Kerma-Strength Standards for 125I and 103Pd Brachytherapy Seeds , 2003, Journal of research of the National Institute of Standards and Technology.

[53]  F. Vicini,et al.  Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. , 2003, International journal of radiation oncology, biology, physics.

[54]  G. Gustafson,et al.  Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants. , 1999, International journal of radiation oncology, biology, physics.

[55]  Kenneth B. Thornton,et al.  Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology. , 2003, Brachytherapy.

[56]  Phantom investigations on CT seed imaging for interstitial brachytherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[57]  R. Taschereau,et al.  Seed misplacement and stabilizing needles in transperineal permanent prostate implants. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[58]  D. Brenner,et al.  Pulsed brachytherapy as a substitute for continuous low dose rate: an in vitro study with human carcinoma cells. , 1997, International journal of radiation oncology, biology, physics.

[59]  D. Heron,et al.  Prescription dose in permanent Cs131 seed prostate implants. , 2005, Medical physics.

[60]  M. Lahanas,et al.  Global convergence analysis of fast multiobjective gradient-based dose optimization algorithms for high-dose-rate brachytherapy. , 2003, Physics in medicine and biology.

[61]  Julie Dawson,et al.  Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants , 1994 .

[62]  C C Ling,et al.  The relative biological effectiveness of I-125 and Pd-103. , 1995, International journal of radiation oncology, biology, physics.

[63]  P. Grigsby,et al.  A treatment planning study comparing HDR and AGIMRT for cervical cancer. , 2004, Medical physics.

[64]  W. Butler,et al.  Erratum: Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations (Medical Physics (2004) 31 (633-674)) , 2004 .

[65]  M. Inbar,et al.  Comparison between two iodine-125 brachytherapy implant techniques: pre-planning and intra-operative by various dosimetry quality indicators. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[66]  J. Battista,et al.  The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd. , 2001, Medical physics.

[67]  F. Vicini,et al.  Breast brachytherapy: North American experience. , 2005, Seminars in radiation oncology.

[68]  J. Battista,et al.  Ytterbium-169: calculated physical properties of a new radiation source for brachytherapy. , 1992, Medical physics.

[69]  Zhe Chen,et al.  Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds. , 2000, Medical physics.

[70]  Harold O. Wyckoff,et al.  International Commission ON Radiation Units and Measurements (ICRU). , 1974, The American journal of roentgenology, radium therapy, and nuclear medicine.

[71]  R L Morin,et al.  Monte Carlo evaluation of the Sievert integral for brachytherapy dosimetry. , 1983, Physics in medicine and biology.

[72]  Cynthia H McCollough,et al.  Quality assurance for computed-tomography simulators and the computed-tomography-simulation process: report of the AAPM Radiation Therapy Committee Task Group No. 66. , 2003, Medical physics.

[73]  M. Esassolak,et al.  Effect of geometrical optimization on the treatment volumes and the dose homogeneity of biplane interstitial brachytherapy implants. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[74]  D. Brenner,et al.  Pulsed-dose-rate brachytherapy: design of convenient (daytime-only) schedules. , 1997, International journal of radiation oncology, biology, physics.

[75]  D H Brinkmann,et al.  Automated seed localization from CT datasets of the prostate. , 1998, Medical physics.

[76]  M. Lahanas,et al.  Multiobjective anatomy-based dose optimization for HDR-brachytherapy with constraint free deterministic algorithms. , 2002, Physics in medicine and biology.

[77]  Eva K. Lee,et al.  Intraoperative dynamic dose optimization in permanent prostate implants. , 2003, International journal of radiation oncology, biology, physics.

[78]  J. Williamson The Sievert integral revisited: evaluation and extension to 125I, 169Yb, and 192Ir brachytherapy sources. , 1996, International journal of radiation oncology, biology, physics.

[79]  G. Montana,et al.  Three-dimensional applicator system for carcinoma of the uterine cervix. , 1997, International journal of radiation oncology, biology, physics.

[80]  Dragan Tubic,et al.  Sliding slice: a novel approach for high accuracy and automatic 3D localization of seeds from CT scans. , 2005, Medical physics.

[81]  Y. Yu,et al.  Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. , 2001, International journal of radiation oncology, biology, physics.

[82]  Omar Chibani,et al.  Dosimetric effects of seed anisotropy and interseed attenuation for Pd103 and I125 prostate implants. , 2005, Medical physics.

[83]  J. Williamson,et al.  High dose-rate brachytherapy treatment delivery: report of the AAPM Radiation Therapy Committee Task Group No. 59. , 1998, Medical physics.

[84]  Lowell L. Anderson,et al.  Interstitial Brachytherapy: Physical, Biological, and Clinical Considerations , 1990 .

[85]  S. Seltzer,et al.  Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy. , 2004, Medical physics.

[86]  C. Orton High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. , 2001, International journal of radiation oncology, biology, physics.

[87]  J. Williamson,et al.  Monte Carlo-based dose-rate tables for the Amersham CDCS.J and 3M model 6500 137Cs tubes. , 1998, International journal of radiation oncology, biology, physics.

[88]  Z Li,et al.  An algorithm for automatic, computed-tomography-based source localization after prostate implant. , 2001, Medical physics.

[89]  E. Tanaka,et al.  An optimization algorithm of dose distribution using attraction-repulsion model (application to low-dose-rate interstitial brachytherapy). , 2004, International journal of radiation oncology, biology, physics.

[90]  Silvia D. Chang,et al.  Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. , 2004, International journal of radiation oncology, biology, physics.

[91]  H. Holm The history of interstitial brachytherapy of prostatic cancer. , 1997, Seminars in surgical oncology.

[92]  Bruce Thomadsen,et al.  Achieving Quality in Brachytherapy , 1999 .

[93]  J. Pow-Sang,et al.  Improvement in dosimetry of ultrasound-guided prostate implants with the use of multiple stabilization needles. , 1996, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[94]  S. Chiu‐Tsao,et al.  High beta and electron dose from 192Ir: implications for "gamma" intravascular brachytherapy. , 2002, International journal of radiation oncology, biology, physics.

[95]  J F Williamson,et al.  Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine. , 1997, Medical physics.

[96]  J Pouliot,et al.  Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function. , 2001, Medical physics.

[97]  J J DeMarco,et al.  CT-based dosimetry calculations for 125I prostate implants. , 1999, International journal of radiation oncology, biology, physics.

[98]  C B Saw,et al.  Reference dose rates for single- and double-plane 192Ir implants. , 1988, Medical physics.

[99]  H. M. Parker,et al.  A Dosage System for Gamma Ray Therapy , 1934 .

[100]  M. Stovall,et al.  31 – DOSIMETRY IN IMPLANT THERAPY1 , 1969 .

[101]  J. Williamson,et al.  A secondary air kerma strength standard for Yb-169 interstitial brachytherapy sources. , 1995, Physics in medicine and biology.

[102]  Dimos Baltas,et al.  The physics of modern brachytherapy for onocology , 2006 .

[103]  R. Das,et al.  ICRU 58 (Dose and Volume Specification for Reporting Interstitial Therapy), by International Commission on Radiation Units and Measurements , 1998 .

[104]  H. M. Parker,et al.  A dosage system for interstitial radium therapy , 1938 .

[105]  A. Gerbaulet,et al.  The GEC ESTRO handbook of brachytherapy , 2002 .

[106]  Brachytherapy for the next century: use of image-based treatment planning. , 1998, Radiation research.

[107]  J. Williamson,et al.  Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. , 2012, Medical physics.